Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal

Neuropharmacology

Volumn 58, Issue 7, 2010, Pages 1140-1146

  Zaniewska, Magdalena ^a   McCreary, Andrew C ^b   Wydra, Karolina ^a   Filip, Małgorzata ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,4,8,9,10,10A OCTAHYDRO 7BH CYCLOPENTA[B][1,4]DIAZEPINO[6,7,1 HI]INDOLE; 2 (6 CHLORO 5 FLUORO 1 INDOLYL) 1 METHYLETHYLAMINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; IMIPRAMINE; NICOTINE; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN RECEPTOR; VOLINANSERIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; DEPRESSION; DRUG EFFICACY; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MALE; MOUSE; NICOTINE WITHDRAWAL SYNDROME; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; SMOKING CESSATION; WITHDRAWAL SYNDROME;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSION; IMIPRAMINE; MALE; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN, 5-HT2; SUBSTANCE WITHDRAWAL SYNDROME; SWIMMING; TIME FACTORS; TREATMENT OUTCOME;

EID: 77950940956     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2010.02.006     Document Type: Article

References (47)

1. Ago Y., Arikawa S., Yata M., Yano K., Abe M., Takuma K., Matsuda T. Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression. Neuropharmacology 2008, 55:1355-1363.
2. Alex K.D., Pehek E.A. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol. Ther. 2007, 113:296-320.
3. Barr A.M., Markou A. Psychostimulant withdrawal as an inducing condition in animal models of depression. Neurosci. Biobehav. Rev. 2005, 29:675-706.
4. 2A/2C receptor agonists. Psychopharmacology 2005, 179:393-401.
5. 2C receptors in the ventral tegmental area. Neuroscience 2007, 146:286-297.
6. Cahill K., Stead L.F., Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst. Rev. 2007, 1:CD006103.
7. Clenet F., De Vos A., Bourin M. Involvement of 5-HT(2C) receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice. Eur. Neuropsychopharmacol. 2001, 11:145-152.
8. Cremers T.I., Giorgetti M., Bosker F.J., Hogg S., Arnt J., Mørk A., Honig G., Bøgesø K.P., Westerink B.H., den Boer H., Wikstrom H.V., Tecott L.H. Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade. Neuropsychopharmacology 2004, 29:1782-1789.
9. Cryan J.F., Gasparini F., van Heeke G., Markou A. Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion. Drug Discov. Today 2003, 8:1025-1034.
10. Cryan J.F., Hoyer D., Markou A. Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents. Biol. Psychiatry 2003, 54:49-58.
11. Cryan J.F., Lucki I. Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors. J. Pharmacol. Exp. Ther. 2000, 295:1120-1126.
12. Cussac D., Newman-Tancredi A., Quentric Y., Carpentier N., Poissonnet G., Parmentier J.G., Goldstein S., Millan M.J. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols. Naunyn-Schmiedeberg's Arch. Pharmacol. 2002, 365:242-252.
13. 2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models. Psychopharmacology 2008, 199:549-568.
14. Di Giovanni G., Di Matteo V., La Grutta V., Esposito E. m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors. Neuroscience 2001, 103:111-116.
15. Dunlop J., Sabb A.L., Mazandarani H., Zhang J., Kalgaonker S., Shukhina E., Sukoff S., Vogel R.L., Stack G., Schechter L., Harrison B.L., Rosenzweig-Lipson S. WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi] indole], a novel 5-hydroxytryptamine 2C receptor-selective agonist with anorectic activity. J. Pharmacol. Exp. Ther. 2005, 313:862-869.
16. Fletcher P.J., Lê A.D., Higgins G.A. Serotonin receptors as potential targets for modulation of nicotine use and dependence. Prog. Brain Res. 2008, 172:361-383.
17. Fletcher P.J., Sinyard J., Higgins G.A. The effects of the 5-HT(2C) receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists. Psychopharmacology 2006, 187:515-525.
18. Frankowska M., Filip M., Przegaliński E. Effects of GABA(B) receptor ligands in animal tests of depression and anxiety. Pharmacol. Rep. 2007, 59:645-655.
19. Frankowska M., Gołda A., Wydra K., Gruca P., Papp M., Filip M. Effects of imipramine or GABA(B) receptor ligands on the immobility, swimming and climbing in the forced swim test in rats following discontinuation of cocaine self-administration. Eur. J. Pharmacol. 2010, 627:142-149.
20. Gilbert P., Allan S. The role of defeat and entrapment (arrested flight) in depression: an exploration of an evolutionary view. Psychol. Med. 1998, 28:585-598.
21. Gobert A., Rivet J.M., Lejeune F., Newman-Tancredi A., Adhumeau-Auclair A., Nicolas J.P., Cistarelli L., Melon C., Millan M.J. Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse 2000, 36:205-221.
22. Grottick A.J., Corrigall W.A., Higgins G.A. Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine. Psychopharmacology 2001, 157:292-298.
23. Hanson L.A., Gorzalka B.B. The influence of corticosterone on serotonergic stereotypy and sexual behavior in the female rat. Behav. Brain Res. 1999, 104:27-35.
24. 2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats. Behav. Brain Res. 2009, 197:323-330.
25. 2C receptors suppresses behavioral responses induced by drugs of abuse. Nat. Med. 2006, 12:324-329.
26. Kenny P.J., Markou A. Neurobiology of the nicotine withdrawal syndrome. Pharmacol. Biochem. Behav. 2001, 70:531-549.
27. Kiraly S.J., Ancill R.J., Dimitrova G. The relationship of endogenous cortisol to psychiatric disorder: a review. Can. J. Psychiatry 1997, 42:415-420.
28. Kitamura Y., Araki H., Gomita Y. Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test. Pharmacol. Biochem. Behav. 2002, 71:63-69.
29. Knight A.R., Misra A., Quirk K., Benwell K., Revell D., Kennett G., Bickerdike M. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 2004, 370:114-123.
30. Levin E.D., Slade S., Johnson M., Petro A., Horton K., Williams P., Rezvani A.H., Rose J.E. Ketanserin, a 5-HT(2) receptor antagonist, decreases nicotine self-administration in rats. Eur. J. Pharmacol. 2008, 600:93-97.
31. 2 receptors. Curr. Drug Targets CNS Neurol. Disord. 2004, 3:11-26.
32. Markou A. Neurobiology of nicotine dependence. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2008, 363:3159-3168.
33. 2C receptor agonists: pharmacological characteristics and therapeutic potential. J. Pharmacol. Exp. Ther. 1998, 286:913-924.
34. 2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats. Eur. Neuropsychopharmacol. 1996, 6:169-175.
35. 2 receptor agonists on the behavioral and neurochemical consequences of repeated nicotine treatment. Eur. J. Pharmacol. 2001, 420:45-54.
36. Patel J.G., Bartoszyk G.D., Edwards E., Ashby C.R. The highly selective 5-hydroxytryptamine (5-HT)2A receptor antagonist, EMD 281014, significantly increases swimming and decreases immobility in male congenital learned helpless rats in the forced swim test. Synapse 2004, 52:73-75.
37. Paterson N.E., Markou A. Animal models and treatments for addiction and depression co-morbidity. Neurotox. Res. 2007, 11:1-32.
38. 2C receptor. Psychopharmacology 1996, 126:234-240.
39. 2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex. Neuropsychopharmacology 2006, 31:265-277.
40. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 1978, 47:379-391.
41. 3 receptors in the activity of antidepressants in the mouse forced swimming test. Eur. J. Pharmacol. 1997, 325:129-135.
42. Rosenzweig-Lipson S., Sabb A., Stack G., Mitchell P., Lucki I., Malberg J.E., Grauer S., Brennan J., Cryan J.F., Sukoff Rizzo S.J., Dunlop J., Barrett J.E., Marquis K.L. Antidepressant-like effects of the novel, selective, 5-HT(2C) receptor agonist WAY-163909 in rodents. Psychopharmacology 2007, 192:159-170.
43. Tasset I., Peña J., Jimena I., Feijóo M., Del Carmen Muñoz M., Montilla P., Túnez I. Effect of 17beta-estradiol on olfactory bulbectomy-induced oxidative stress and behavioral changes in rats. Neuropsychiatr. Dis. Treat. 2008, 4:441-449.
44. Yasuda K., Suemaru K., Araki H., Gomita Y. Effect of nicotine cessation on the central serotonergic systems in mice: involvement of 5-HT(2) receptors. Naunyn-Schmiedeberg's Arch. Pharmacol 2002, 366:276-281.
45. Zaniewska M., McCreary A.C., Filip M. Interactions of serotonin (5-HT)(2) receptor-targeting ligands and nicotine: locomotor activity studies in rats. Synapse 2009, 63:653-661.
46. 2C receptor ligands on the discriminative stimulus effects of nicotine in rats. Eur. J. Pharmacol. 2007, 571:156-165.
47. Zaniewska M., McCreary A.C., Sezer G., Przegaliński E., Filip M. Effects of agmatine on nicotine-evoked behavioral responses in rats. Pharmacol. Rep. 2008, 60:645-654.